Shuttle Pharmaceuticals Holdings, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
401 PROFESSIONAL DRIVE, GAITHERSBURG, MD, 20879
Mailing Address
401 PROFESSIONAL DRIVE, GAITHERSBURG, MD, 20879
Phone
(240) 403-4212
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 10, 2026 | View on SEC |
| 8-K Current report of material events | February 17, 2026 | View on SEC |
| S-1 IPO registration statement | February 11, 2026 | View on SEC |
| S-1/A IPO registration amendment | February 11, 2026 | View on SEC |
| 8-K Current report of material events | February 2, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 3 Initial insider ownership report | January 12, 2026 | View on SEC |
| 8-K Current report of material events | December 29, 2025 | View on SEC |
| S-1/A IPO registration amendment | December 11, 2025 | View on SEC |
Annual Reports
10-K
March 31, 2026
- Strategic pivot from traditional drug development to an AI-driven pharmaceutical research platform.
- Acquisition of Molecule.ai for $10 million in stock to anchor new AI technology business model.
Material Events
8-K
Acquisition
December 29, 2025
High Impact
- Shuttle Pharmaceuticals issued 320,496 new common shares to 1542770 BC Ltd. as an accelerated payment.
- This share issuance covers a portion of the 'First Installment Payment' for an ongoing asset acquisition.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.